ArticleResearch square2024

Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

Tejaswini Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.